Summary
- A common clinical entity, comprising 2% to 4% of all incident cancers worldwide.
- Untreated, prognosis is poor, with a median survival between 3 and 4 months.
- A key goal in the diagnostic work-up is to identify subsets of patients with a more favourable clinico-pathological subtype and likely better outcome.
- Systemic chemotherapy is the mainstay of treatment. Supportive therapies control pain and other symptoms.
Other related conditions
- Anaemia of chronic disease
- Assessment of anaemia
- Assessment of neutropenia
- Carcinoid syndrome
- Colorectal cancer
- Febrile neutropenia
- Non-small cell lung cancer
- Metastatic breast cancer
- Ovarian cancer
- Pituitary adenoma
- Prostate cancer
- Small cell lung cancer
- Squamous cell carcinoma of the skin
- Testicular cancer
- VIPoma
Last updated: Nov 21, 2012
